Pancreatitis Although less common, some studies have shown an increased risk of pancreatitis, an inflammation of the pancreas, in patients using GLP-1 medications
COAs include purity results, identity confirmation data, analytical methods used, batch number, and test date
In SURMOUNT-2, the mean WL was up to 15.7% with tirzepatide 15 mg compared to 3.3% WL with placebo at 72 weeks for people with obesity and T2D [47]
(2022) analyzing 10 clinical trials found that the KD consistently reduced migraine frequency and severity with minimal side effects
Every reconstitution event carries a small risk of contamination or measurement error, so fewer events means more consistent results across your protocol
Having people who support you makes success more likely